Valor Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209M | Hold |
6,618,033
| – | – | 87.82% | 1 |
|
|
2025
Q1 | $220M | Hold |
6,618,033
| – | – | 91.3% | 1 |
|
|
2024
Q4 | $228M | Sell |
6,618,033
-4,600,000
| -41% | -$158M | 91.4% | 1 |
|
|
2024
Q3 | $449M | Hold |
11,218,033
| – | – | 94.55% | 1 |
|
|
2024
Q2 | $338M | Hold |
11,218,033
| – | – | 74.43% | 1 |
|
|
2024
Q1 | $377M | Hold |
11,218,033
| – | – | 78.55% | 1 |
|
|
2023
Q4 | $362M | Hold |
11,218,033
| – | – | 99.55% | 1 |
|
|
2023
Q3 | $368M | Hold |
11,218,033
| – | – | 98.94% | 1 |
|
|
2023
Q2 | $395M | Hold |
11,218,033
| – | – | 98.29% | 1 |
|
|
2023
Q1 | $366M | Hold |
11,218,033
| – | – | 96.46% | 1 |
|
|
2022
Q4 | $618M | Hold |
11,218,033
| – | – | 97.5% | 1 |
|
|
2022
Q3 | $497M | Hold |
11,218,033
| – | – | 95.45% | 1 |
|
|
2022
Q2 | $547M | Hold |
11,218,033
| – | – | 96.54% | 1 |
|
|
2022
Q1 | $546M | Hold |
11,218,033
| – | – | 83.25% | 1 |
|
|
2021
Q4 | $478M | Buy |
+11,218,033
| New | +$478M | 76.2% | 1 |
|